FIELD: medicine.
SUBSTANCE: group of inventions refers to application of nerve growth factor (NGF) antibodies (anti-NGF antibodies) for pain management, physical function improvement and rigidity decrease in an individual suffering osteoarthritis. There are presented: a method of pain management, physical function improvement and rigidity decrease in an individual suffering osteoarthritis involves administration to the specified individual of an effective amount of anti-NGF antibodies, and also a kit and a pharmaceutical composition for implementing such method of management.
EFFECT: pain relief, physical function improvement and rigidity decrease in the patients suffering osteoarthritis.
24 cl, 23 tbl, 9 ex, 27 dwg
Authors
Dates
2011-09-20—Published
2006-04-11—Filed